Drreddys Laboratories reported INR11.1 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.12 0.12 0.20 Oct/23
FY2027Q4 Mar/2026 0.06 0.13 0.22 May/12




Eps Change Date
ANI Pharmaceuticals USD 2.21 0.16 Jun/2026
Aurora Cannabis CAD -0.07 0.06 Jun/2026
Bayer EUR 0.31 0.64 Sep/2026
Canopy Growth CAD -0.03 0.37 Jun/2026
Cipla INR 10.85 1.09 Sep/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Drreddys Laboratories INR 11.1 11.04 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lonza CHF 6.07 1.92 Jun/2025
Novartis USD 2.46 0.05 Sep/2026
Pacira USD 0.73 0.13 Jun/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Richter Gedeon HUF 209.24 120.15 Jun/2026
Sun Pharmaceuticals INR 13.2 0.09 Sep/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026